Inapropriate Use N(%) | Appropriate Use N(%) | P value | |
---|---|---|---|
Age, mean ± SDa | 64.3 ± 18.7 | 61.6 ± 20.8 | .522 |
Genderb | |||
Female | 78 (47) | 16 (47.1) | .994 |
Male | 88 (53) | 18 (52.9) | |
BMI (kg/m2), mean ± SDa | 26.3 ± 6.24 | 27.0 ± 5.68 | .228 |
CCI, mean ± SDa | 4.51 ± 2.48 | 3.82 ± 2.35 | .200 |
ICUb | |||
Medical | 95 (57.2) | 20 (58.8) | .864 |
Surgical | 71 (42.8) | 14 (41.2) | |
Duration of Hospital Stay ± SDa (Day) | 23.2 ± 27.0 | 20.9 ± 26.6 | .439 |
Duration of ICU stay ± SDa (Day) | 16.8 ± 25.8 | 16.5 ± 27.6 | .591 |
Source of Infectionb | |||
Sepsis | 70 (49.3) | 9 (29) | .040 |
Septic Schock | 59 (30.5) | 7 (20.6) | .091 |
Pneumoniae | 111 (66.9) | 20 (58.8) | .369 |
Blood Stream Infection (BSI) | 46 (27.9) | 5 (14.7) | .109 |
Others | 20 (12.0) | 11 (32.4) | .003 |
Unknown | 32 (19.3) | 3 (8.8) | .118 |
Antibiotic treatment approachb | |||
Emprical therapy | 114 (68.7) | 18 (52.9) | .078 |
Agent spesific therapy | 52 (31.3) | 16 (47.1) | |
Central Venous Catheter | 109 (65.7) | 16 (47.1) | .041 |
Laboratory Paremetersa | |||
WBC (×10.e3/μL), mean ± SD | 14.672 ± 19.179 | 14.802 ± 10.087 | .460 |
PLT (×10.e3/μL), mean ± SD | 221.879 ± 139.955 | 244.323 ± 156.829 | .482 |
Lactate (mMol/L), mean ± SD | 2.06 ± 1.70 | 2.22 ± 1.91 | .644 |
GFR (mL/min), mean ± SD | 50.6 ± 32.5 | 69.4 ± 26.8 | .001 |
Cr (mg/ dL), mean ± SD | 1.93 ± 1.74 | 0.90 ± 0.79 | <.001 |
CRP (mg/L), mean ± SD | 133 ± 92.8 | 156 ± 112 | .041 |
Procalcitonin (ng/ mL), mean ± SD | 18.7 ± 85.5 | 14.9 ± 68.5 | .013 |